Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia

Cih En Huang, Yi Yang Chen, Jung Jung Chang, Feng Che Kuan, Kuan Der Lee, Chang Hsien Lu, Jrhau Lung, Chien Heng Shen, Chih Cheng Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives: Complex and multiple mechanisms are involved in the etiology of Hepatitis C virus-associated immune thrombocytopenia (HCV-ITP). Many hematopoietic growth factors affect the thrombopoiesis. The aim of this study was to clarify the interaction of the thrombopoietic factors in patients with HCV-ITP. Methods: We selected 33 patients with HCV-ITP and 17 normal individuals. We compare serum interleukin (IL)-3, IL-6, IL-11, thrombopoietin (Tpo), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor-α (TNFα), and spleen size between these two groups. Results: Our study shows that Tpo, IL-6, and TNFα significantly increased in patients with HCV-ITP compared to the normal population (Tpo:122.577 vs. 40.602; IL-6: 2.175 vs. 0.943; TNFα: 2.460 vs. 1.322). IL-11 was significantly lower in the HCV-ITP group (10.829 vs. 15.042). HCV-ITP patients had a higher spleen index (21.121 vs 13.498, P = 0.003). According to regression analysis and multiple linear regression analysis, only IL-11 had a significantly positive correlation with platelet count, while TNFα showed a negative correlation. Discussions: Tpo and IL-6 increased in patients with HCV-ITP, suggesting a positive feedback of low platelet count. TNFα-associated immune response is suspected to have an impact on low platelet count. IL-11 is assumed to directly affect thrombopoiesis. Conclusions: This study is the most comprehensive study to evaluate the interaction between platelet count and the important thrombopoetic factors in patients with HCV-ITP. The thrombopoietic factors clearly play an important role in HCV-ITP.

Original languageEnglish
Pages (from-to)54-60
Number of pages7
JournalHematology
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 2 2017
Externally publishedYes

Fingerprint

Idiopathic Thrombocytopenic Purpura
Hepacivirus
Cytokines
Interleukin-11
Thrombopoietin
Platelet Count
Tumor Necrosis Factor-alpha
Interleukin-6
Thrombopoiesis
Spleen
Regression Analysis
Stem Cell Factor
Interleukin-3
Granulocyte-Macrophage Colony-Stimulating Factor
Linear Models
Intercellular Signaling Peptides and Proteins

Keywords

  • Cytokine
  • Hepatitis C
  • Immune thrombocytopenia
  • Interleukin
  • Spleen
  • Thrombopoietin

ASJC Scopus subject areas

  • Hematology

Cite this

Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia. / Huang, Cih En; Chen, Yi Yang; Chang, Jung Jung; Kuan, Feng Che; Lee, Kuan Der; Lu, Chang Hsien; Lung, Jrhau; Shen, Chien Heng; Chen, Chih Cheng.

In: Hematology, Vol. 22, No. 1, 02.01.2017, p. 54-60.

Research output: Contribution to journalArticle

Huang, CE, Chen, YY, Chang, JJ, Kuan, FC, Lee, KD, Lu, CH, Lung, J, Shen, CH & Chen, CC 2017, 'Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia', Hematology, vol. 22, no. 1, pp. 54-60. https://doi.org/10.1080/10245332.2016.1204493
Huang, Cih En ; Chen, Yi Yang ; Chang, Jung Jung ; Kuan, Feng Che ; Lee, Kuan Der ; Lu, Chang Hsien ; Lung, Jrhau ; Shen, Chien Heng ; Chen, Chih Cheng. / Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia. In: Hematology. 2017 ; Vol. 22, No. 1. pp. 54-60.
@article{f9913a75bb5948cbb0f9b9e368ab3c53,
title = "Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia",
abstract = "Objectives: Complex and multiple mechanisms are involved in the etiology of Hepatitis C virus-associated immune thrombocytopenia (HCV-ITP). Many hematopoietic growth factors affect the thrombopoiesis. The aim of this study was to clarify the interaction of the thrombopoietic factors in patients with HCV-ITP. Methods: We selected 33 patients with HCV-ITP and 17 normal individuals. We compare serum interleukin (IL)-3, IL-6, IL-11, thrombopoietin (Tpo), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor-α (TNFα), and spleen size between these two groups. Results: Our study shows that Tpo, IL-6, and TNFα significantly increased in patients with HCV-ITP compared to the normal population (Tpo:122.577 vs. 40.602; IL-6: 2.175 vs. 0.943; TNFα: 2.460 vs. 1.322). IL-11 was significantly lower in the HCV-ITP group (10.829 vs. 15.042). HCV-ITP patients had a higher spleen index (21.121 vs 13.498, P = 0.003). According to regression analysis and multiple linear regression analysis, only IL-11 had a significantly positive correlation with platelet count, while TNFα showed a negative correlation. Discussions: Tpo and IL-6 increased in patients with HCV-ITP, suggesting a positive feedback of low platelet count. TNFα-associated immune response is suspected to have an impact on low platelet count. IL-11 is assumed to directly affect thrombopoiesis. Conclusions: This study is the most comprehensive study to evaluate the interaction between platelet count and the important thrombopoetic factors in patients with HCV-ITP. The thrombopoietic factors clearly play an important role in HCV-ITP.",
keywords = "Cytokine, Hepatitis C, Immune thrombocytopenia, Interleukin, Spleen, Thrombopoietin",
author = "Huang, {Cih En} and Chen, {Yi Yang} and Chang, {Jung Jung} and Kuan, {Feng Che} and Lee, {Kuan Der} and Lu, {Chang Hsien} and Jrhau Lung and Shen, {Chien Heng} and Chen, {Chih Cheng}",
year = "2017",
month = "1",
day = "2",
doi = "10.1080/10245332.2016.1204493",
language = "English",
volume = "22",
pages = "54--60",
journal = "Hematology",
issn = "1024-5332",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia

AU - Huang, Cih En

AU - Chen, Yi Yang

AU - Chang, Jung Jung

AU - Kuan, Feng Che

AU - Lee, Kuan Der

AU - Lu, Chang Hsien

AU - Lung, Jrhau

AU - Shen, Chien Heng

AU - Chen, Chih Cheng

PY - 2017/1/2

Y1 - 2017/1/2

N2 - Objectives: Complex and multiple mechanisms are involved in the etiology of Hepatitis C virus-associated immune thrombocytopenia (HCV-ITP). Many hematopoietic growth factors affect the thrombopoiesis. The aim of this study was to clarify the interaction of the thrombopoietic factors in patients with HCV-ITP. Methods: We selected 33 patients with HCV-ITP and 17 normal individuals. We compare serum interleukin (IL)-3, IL-6, IL-11, thrombopoietin (Tpo), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor-α (TNFα), and spleen size between these two groups. Results: Our study shows that Tpo, IL-6, and TNFα significantly increased in patients with HCV-ITP compared to the normal population (Tpo:122.577 vs. 40.602; IL-6: 2.175 vs. 0.943; TNFα: 2.460 vs. 1.322). IL-11 was significantly lower in the HCV-ITP group (10.829 vs. 15.042). HCV-ITP patients had a higher spleen index (21.121 vs 13.498, P = 0.003). According to regression analysis and multiple linear regression analysis, only IL-11 had a significantly positive correlation with platelet count, while TNFα showed a negative correlation. Discussions: Tpo and IL-6 increased in patients with HCV-ITP, suggesting a positive feedback of low platelet count. TNFα-associated immune response is suspected to have an impact on low platelet count. IL-11 is assumed to directly affect thrombopoiesis. Conclusions: This study is the most comprehensive study to evaluate the interaction between platelet count and the important thrombopoetic factors in patients with HCV-ITP. The thrombopoietic factors clearly play an important role in HCV-ITP.

AB - Objectives: Complex and multiple mechanisms are involved in the etiology of Hepatitis C virus-associated immune thrombocytopenia (HCV-ITP). Many hematopoietic growth factors affect the thrombopoiesis. The aim of this study was to clarify the interaction of the thrombopoietic factors in patients with HCV-ITP. Methods: We selected 33 patients with HCV-ITP and 17 normal individuals. We compare serum interleukin (IL)-3, IL-6, IL-11, thrombopoietin (Tpo), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor-α (TNFα), and spleen size between these two groups. Results: Our study shows that Tpo, IL-6, and TNFα significantly increased in patients with HCV-ITP compared to the normal population (Tpo:122.577 vs. 40.602; IL-6: 2.175 vs. 0.943; TNFα: 2.460 vs. 1.322). IL-11 was significantly lower in the HCV-ITP group (10.829 vs. 15.042). HCV-ITP patients had a higher spleen index (21.121 vs 13.498, P = 0.003). According to regression analysis and multiple linear regression analysis, only IL-11 had a significantly positive correlation with platelet count, while TNFα showed a negative correlation. Discussions: Tpo and IL-6 increased in patients with HCV-ITP, suggesting a positive feedback of low platelet count. TNFα-associated immune response is suspected to have an impact on low platelet count. IL-11 is assumed to directly affect thrombopoiesis. Conclusions: This study is the most comprehensive study to evaluate the interaction between platelet count and the important thrombopoetic factors in patients with HCV-ITP. The thrombopoietic factors clearly play an important role in HCV-ITP.

KW - Cytokine

KW - Hepatitis C

KW - Immune thrombocytopenia

KW - Interleukin

KW - Spleen

KW - Thrombopoietin

UR - http://www.scopus.com/inward/record.url?scp=84978540580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978540580&partnerID=8YFLogxK

U2 - 10.1080/10245332.2016.1204493

DO - 10.1080/10245332.2016.1204493

M3 - Article

C2 - 27396368

AN - SCOPUS:84978540580

VL - 22

SP - 54

EP - 60

JO - Hematology

JF - Hematology

SN - 1024-5332

IS - 1

ER -